Sertraline in the treatment of anxiety disorders Academic Article uri icon

Overview

MeSH Major

  • Panic Disorder
  • Serotonin Uptake Inhibitors
  • Sertraline

abstract

  • Sertraline was first developed and approved for the treatment of depression. However, considerable research has been conducted on its use in anxiety disorders. This paper reviews the data emerging from controlled and open trials of the use of sertraline in anxiety disorders. Sertraline has been tested extensively in the treatment of panic and obsessive-compulsive disorders. Less extensive testing has been completed on social phobia and post-traumatic stress disorder. The reviewed studies show that sertraline is an effective and well-tolerated treatment of all of these disorders. A comparison of sertraline with other pharmacotherapeutic options shows it to be at least equivalent to other medications for anxiety disorders.

publication date

  • August 21, 2000

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/1520-6394(2000)11:4<139::AID-DA1>3.0.CO;2-C

PubMed ID

  • 10945134

Additional Document Info

start page

  • 139

end page

  • 57

volume

  • 11

number

  • 4